Get startedLog in
    Picture of ORYZON Genomics SA logo

    ORY — ORYZON Genomics SA News Story

    0.000.00%
    es flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapSucker Stock
    All News

    Brief: Oryzon Presents Final Data From Vafidemstat’s Phase IIb Portico Trial In Borderline Personality Disorder

    Picture of ORYZON Genomics SA logoORYZON Genomics SA
    23/09/2024 07:13
    Sept 23 (Reuters) - Oryzon Genomics SA  ORY.MC :
    * PRESENTS FINAL DATA FROM VAFIDEMSTAT’S PHASE IIB PORTICO TRIAL IN BORDERLINE PERSONALITY
DISORDER

Source text for Eikon:  ID:nCNM4Pjpn2 
Further company coverage:  ORY.MC 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

    Recent news on ORYZON Genomics SA

    See all news